Skip to content

Rheuma Pics Hub
Rheuma Calculator
Books
Login
Register
Rheuma Tv in 2024

Home
Student Corner
- PG Section
- UG Section
Case Discussion
Research
- Journal Club
Webinar
News and Views
Conference
Quiz
Courses

Tildrakizumab

Phases IIa trial reports that tildrakizumab treatment did not improve ASAS20 response rate in ankylosing spondylitis patients

Important Links

Privacy Policy
Contact Us
Disclaimer
About Us
Terms and Conditions
Cancellation Policy
Refund Policy
Partner With Us

Disclaimer

This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. @2020 ChanRe Healthcare & Research Pvt Ltd.

Copyright © 2026

Home
Student Corner
- PG Section
- UG Section
Case Discussion
Research
- Journal Club
Webinar
News and Views
Conference
Quiz
Courses

Search for:

Security Verification

For security purposes, please solve this simple puzzle to verify you are human before sending an OTP.

Puzzle Question

=

Search for: